Biotech ETF Channel

Interest rates hit their highest levels in a year on Wednesday, putting pressure on long-duration assets.

The new fund targets themes demonstrating disruptive innovation.

Not every viable ETF gathers large amounts of assets right out of the gate.

Also, these are the cities with the riskiest housing markets.

Global X's new telemedicine fund proves to be the right ETF for the right moment.

Joining us is Kristina Hooper, chief global market strategist at Invesco.

New fund invests in small cap biotechnology stocks. 

An unusually high number of launches in June boosted the open-to-close ratio.